These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22532156)

  • 1. The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17A deleted dominant negative form of transforming growth factor beta receptor type II mice.
    Ando Y; Yang GX; Tsuda M; Kawata K; Zhang W; Nakajima T; Tsuneyama K; Leung P; Lian ZX; Okazaki K; Ridgway WM; Norman GL; Ansari AA; He XS; Coppel RL; Gershwin ME
    Hepatology; 2012 Oct; 56(4):1418-26. PubMed ID: 22532156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis.
    Zhang W; Tsuda M; Yang GX; Tsuneyama K; Rong G; Ridgway WM; Ansari AA; Flavell RA; Coppel RL; Lian ZX; Gershwin ME
    Hepatology; 2010 Jul; 52(1):215-22. PubMed ID: 20578264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosis.
    Kawata K; Tsuda M; Yang GX; Zhang W; Tanaka H; Tsuneyama K; Leung P; He XS; Knechtle S; Ansari AA; Coppel RL; Gershwin ME
    PLoS One; 2013; 8(9):e74225. PubMed ID: 24040208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice.
    Yoshida K; Yang GX; Zhang W; Tsuda M; Tsuneyama K; Moritoki Y; Ansari AA; Okazaki K; Lian ZX; Coppel RL; Mackay IR; Gershwin ME
    Hepatology; 2009 Nov; 50(5):1494-500. PubMed ID: 19676134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous interleukin-22 protects against inflammatory bowel disease but not autoimmune cholangitis in dominant negative form of transforming growth factor beta receptor type II mice.
    Yang GX; Sun Y; Tsuneyama K; Zhang W; Leung PS; He XS; Ansari AA; Bowlus C; Ridgway WM; Gershwin ME
    Clin Exp Immunol; 2016 Aug; 185(2):154-64. PubMed ID: 27148790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential modulation by IL-17A of Cholangitis versus Colitis in IL-2Rα deleted mice.
    Yang W; Yao Y; Yang YQ; Lu FT; Li L; Wang YH; Nakajima T; Tsuneyama K; Ridgway WM; Gershwin ME; Lian ZX
    PLoS One; 2014; 9(8):e105351. PubMed ID: 25133396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFβ receptor type II mice.
    Tsuda M; Zhang W; Yang GX; Tsuneyama K; Ando Y; Kawata K; Park O; Leung PS; Coppel RL; Ansari AA; Ridgway WM; Gao B; Lian ZX; Flavell R; He XS; Gershwin ME
    Hepatology; 2013 Feb; 57(2):806-16. PubMed ID: 22576253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-β receptor type II mouse.
    Ando Y; Yang GX; Kenny TP; Kawata K; Zhang W; Huang W; Leung PS; Lian ZX; Okazaki K; Ansari AA; He XS; Invernizzi P; Ridgway WM; Lu Q; Gershwin ME
    J Autoimmun; 2013 Mar; 41():111-9. PubMed ID: 23395552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct from its canonical effects, deletion of IL-12p40 induces cholangitis and fibrosis in interleukin-2Rα(-/-) mice.
    Yao Y; Yang W; Yang YQ; Ma HD; Lu FT; Li L; Tao YY; Tsuneyama K; Zhang W; Friedman S; Gershwin ME; Lian ZX
    J Autoimmun; 2014 Jun; 51():99-108. PubMed ID: 24651036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice.
    Elson CO; Cong Y; Weaver CT; Schoeb TR; McClanahan TK; Fick RB; Kastelein RA
    Gastroenterology; 2007 Jun; 132(7):2359-70. PubMed ID: 17570211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice.
    Yang GX; Lian ZX; Chuang YH; Moritoki Y; Lan RY; Wakabayashi K; Ansari AA; Flavell RA; Ridgway WM; Coppel RL; Tsuneyama K; Mackay IR; Gershwin ME
    Hepatology; 2008 Jun; 47(6):1974-82. PubMed ID: 18452147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compartmentalized expression of Th1 and Th17 cytokines in pediatric inflammatory bowel diseases.
    Verdier J; Begue B; Cerf-Bensussan N; Ruemmele FM
    Inflamm Bowel Dis; 2012 Jul; 18(7):1260-6. PubMed ID: 21994045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells.
    Huang W; Kachapati K; Adams D; Wu Y; Leung PS; Yang GX; Zhang W; Ansari AA; Flavell RA; Gershwin ME; Ridgway WM
    J Autoimmun; 2014 May; 50():123-34. PubMed ID: 24556277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFβRII mice.
    Kawata K; Yang GX; Ando Y; Tanaka H; Zhang W; Kobayashi Y; Tsuneyama K; Leung PS; Lian ZX; Ridgway WM; Ansari AA; He XS; Gershwin ME
    Hepatology; 2013 Sep; 58(3):1094-104. PubMed ID: 23532950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue specific CD4+ T cell priming determines the requirement for interleukin-23 in experimental arthritis.
    Olalekan SA; Cao Y; Finnegan A
    Arthritis Res Ther; 2014 Sep; 16(5):440. PubMed ID: 25253467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of gut inflammation and th17 cell response by interleukin-21.
    Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
    Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis.
    Conti HR; Shen F; Nayyar N; Stocum E; Sun JN; Lindemann MJ; Ho AW; Hai JH; Yu JJ; Jung JW; Filler SG; Masso-Welch P; Edgerton M; Gaffen SL
    J Exp Med; 2009 Feb; 206(2):299-311. PubMed ID: 19204111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KSR1 protects from interleukin-10 deficiency-induced colitis in mice by suppressing T-lymphocyte interferon-γ production.
    Goettel JA; Scott Algood HM; Olivares-Villagómez D; Washington MK; Chaturvedi R; Wilson KT; Van Kaer L; Polk DB
    Gastroenterology; 2011 Jan; 140(1):265-74. PubMed ID: 20875416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pivotal role of cerebral interleukin-23 during immunologic injury in delayed cerebral ischemia in mice.
    Zheng Y; Zhong D; Chen H; Ma S; Sun Y; Wang M; Liu Q; Li G
    Neuroscience; 2015 Apr; 290():321-31. PubMed ID: 25637493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-21, not IL-17A, exacerbates murine primary biliary cholangitis.
    Chan CW; Chen HW; Wang YW; Lin CI; Chuang YH
    Clin Exp Immunol; 2024 Feb; 215(2):137-147. PubMed ID: 37708215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.